IONS Cash-Secured Put Strategy
IONS (Ionis Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Founded in 1989 and headquartered in Carlsbad, California, Ionis Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapies within the United States. Its commercial portfolio includes three key medications: SPINRAZA, prescribed for spinal muscular atrophy (SMA) in both children and adults; TEGSEDI, an injectable treatment targeting polyneuropathy associated with hereditary transthyretin-mediated amyloidosis in adult patients; and WAYLIVRA, which addresses familial chylomicronemia syndrome and familial partial lipodystrophy. Ionis also maintains a robust pipeline, with several drug candidates currently in Phase 3 clinical trials. These include Eplontersen, a monthly self-administered subcutaneous injection designed for all forms of TTR amyloidosis; Olezarsen, intended for individuals with severe hypertriglyceridemia (SHTG); Donidalorsen, for patients suffering from hereditary angioedema; ION363, aimed at amyotrophic lateral sclerosis (ALS); Pelacarsen, developed for those with established cardiovascular disease and elevated lipoprotein(a); and Tofersen, which works by inhibiting the production of superoxide dismutase 1. Beyond these late-stage assets, the company is actively researching treatments for metabolic, infectious, renal, and ophthalmic diseases, as well as various types of cancer. The firm engages in significant collaborations, notably a strategic partnership with Biogen Inc.
IONS (Ionis Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $13.42B, a beta of 0.37 versus the broader market, a 52-week range of 39.37-86.74, average daily share volume of 1.8M, a public-listing history dating back to 1991, approximately 1K full-time employees. These structural characteristics shape how IONS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.37 indicates IONS has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a cash-secured put on IONS?
A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.
Current IONS snapshot
As of June 30, 2026, spot at $79.57, ATM IV 47.80%, IV rank 6.75%, expected move 13.70%. The cash-secured put on IONS below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this cash-secured put structure on IONS specifically: IONS IV at 47.80% is on the cheap side of its 1-year range, which means a premium-selling IONS cash-secured put collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 13.70% (roughly $10.90 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated IONS expiries trade a higher absolute premium for lower per-day decay. Position sizing on IONS should anchor to the underlying notional of $79.57 per share and to the trader's directional view on IONS stock.
IONS cash-secured put setup
The IONS cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With IONS near $79.57, the first option leg uses a $75.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed IONS chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 IONS shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Sell 1 | Put | $75.00 | $2.15 |
IONS cash-secured put risk and reward
- Net Premium / Debit
- +$215.00
- Max Profit (per contract)
- $215.00
- Max Loss (per contract)
- -$7,284.00
- Breakeven(s)
- $72.85
- Risk / Reward Ratio
- 0.030
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.
IONS cash-secured put payoff curve
Modeled P&L at expiration across a range of underlying prices for the cash-secured put on IONS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$7,284.00 |
| $17.60 | -77.9% | -$5,524.77 |
| $35.19 | -55.8% | -$3,765.55 |
| $52.79 | -33.7% | -$2,006.32 |
| $70.38 | -11.6% | -$247.10 |
| $87.97 | +10.6% | +$215.00 |
| $105.56 | +32.7% | +$215.00 |
| $123.16 | +54.8% | +$215.00 |
| $140.75 | +76.9% | +$215.00 |
| $158.34 | +99.0% | +$215.00 |
When traders use cash-secured put on IONS
Cash-secured puts on IONS earn premium while a trader waits to acquire IONS stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning IONS.
IONS thesis for this cash-secured put
The market-implied 1-standard-deviation range for IONS extends from approximately $68.67 on the downside to $90.47 on the upside. A IONS cash-secured put lets a trader earn premium while waiting to acquire IONS at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current IONS IV rank near 6.75% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on IONS at 47.80%. As a Healthcare name, IONS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to IONS-specific events.
IONS cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. IONS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move IONS alongside the broader basket even when IONS-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on IONS carry tail risk when realized volatility exceeds the implied move; review historical IONS earnings reactions and macro stress periods before sizing. Always rebuild the position from current IONS chain quotes before placing a trade.
Frequently asked questions
- What is a cash-secured put on IONS?
- A cash-secured put on IONS is the cash-secured put strategy applied to IONS (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With IONS stock trading near $79.57, the strikes shown on this page are snapped to the nearest listed IONS chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are IONS cash-secured put max profit and max loss calculated?
- Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the IONS cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 47.80%), the computed maximum profit is $215.00 per contract and the computed maximum loss is -$7,284.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a IONS cash-secured put?
- The breakeven for the IONS cash-secured put priced on this page is roughly $72.85 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current IONS market-implied 1-standard-deviation expected move is approximately 13.70%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a cash-secured put on IONS?
- Cash-secured puts on IONS earn premium while a trader waits to acquire IONS stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning IONS.
- How does current IONS implied volatility affect this cash-secured put?
- IONS ATM IV is at 47.80% with IV rank near 6.75%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.